Showing posts from tagged with: BRCA 1

Pathway Genomics Launches BreastTrue NGS High Risk Breast Cancer Panel with PALB2

Posted on 09/10/2014 in News, Press Releases

SAN DIEGO, CASeptember 10. 2014 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, today announced it has launched BreastTrueTM High Risk Panel, a next-generation sequencing test with deletion/duplication analysis to detect mutations in seven high-risk breast cancer susceptibility genes, including BRCA1, BRCA2 and PALB2.